Perrigo Company plc
PRGOHealthcareNASDAQDrug Manufacturers - Specialty & Generic · Last scanned Sep 9, 2026
Scan Results
Daily timeframePerrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. At a $2.02B market cap, Perrigo Company plc ranks as a mid-cap company within healthcare. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments.
Market Cap
$2.02B
Beta
0.60
P/E (TTM)
—
P/E (Fwd)
6.08
EPS (TTM)
$-12.29
EPS (Fwd)
$2.40
ROE
-48.8%
ROA
2.0%
Cash
$399.7M
Total Debt
$3.48B
Free CF
$437.2M
52W Change
-32.6%
Annual Financials
Cash vs Debt
Where PRGO stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, PRGO finished 29.26% above its 150-day moving average ($11.21) and 24.48% above its 200-day moving average ($11.64). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is PRGO overbought or oversold?
At the September 3, 2026 close, PRGO's RSI(14) was 73.7, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $399.7M in cash, though total debt stands at $3.48B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $437.2M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -48.8% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.0% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $4.45B (2022) to $4.25B (2025).
The relatively low beta of 0.60 suggests PRGO is a less volatile holding compared to the broader index. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Perrigo Company plc's trajectory.